FDA requires more details on MannKind's Afrezza - Reuters

[INCIID News Feed]

<img alt="" height="1" width="1" />
FDA requires more details on MannKind&#39;s Afrezza
Reuters
BOSTON, March 15 (Reuters) - US regulators have requested more information on an inhaled insulin device being developed by MannKind Corp (MNKD.O), the company said on Monday, sending its shares down nearly 10 percent in mid-morning ...
MannKind&#39;s Insulin Afrezza Fails to Win ApprovalBusinessWeek
MannKind&#39;s inhaled insulin drug Afrezza delayedFierceBiotech
FDA Seeks Additional Information On MannKind&#39;s Insulin Therapy Afrezza - UpdateRTT News
TheStreet.com (subscription) -Trading Markets (press release) -MarketWatch (press release)
all 25 news articles &raquo;


More...